The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood–brain barrier of rats

References

• Agarwal S, Hartz AMS, Elmquist WF, Bauer B. (2011). Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Curr Pharm Des 17:2793–802
   PubMed Web of Science ®Google Scholar
• Al-Ansari AM, Saleem A, Kimpe LE, et al. (2010). Bioaccumulation of the pharmaceutical 17alpha-ethinylestradiol in shorthead redhorse suckers (Moxostoma macrolepidotum) from the St. Clair River, Canada. Environ Pollut 158:2566–71
   PubMed Web of Science ®Google Scholar
• Anapolsky A, Teng S, Dixit S, Piquette-Miller M. (2006). The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice. Drug Metab Dispos 34:405–9
   PubMed Web of Science ®Google Scholar
• Breedveld P, Pluim D, Cipriani G, et al. (2005). The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res 65:2577–82
   PubMed Web of Science ®Google Scholar
• Cisternino S, Mercier C, Bourasset F, et al. (2004). Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res 64:3296–301
   PubMed Web of Science ®Google Scholar
• Crain DA, Eriksen M, Iguchi T, et al. (2007). An ecological assessment of bisphenol-A: evidence from comparative biology. Reprod Toxicol 24:225–39
   PubMed Web of Science ®Google Scholar
• Dankers ACA, Roelofs MJE, Piersma AH, et al. (2013). Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. Toxicol Sci 136:382–91
   Google Scholar
• de Vries NA, Zhao J, Kroon E, et al. (2007). P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin Cancer Res 13:6440–9
   PubMed Web of Science ®Google Scholar
• Deuring JJ, de Haar C, Koelewijn CL, et al. (2012). Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding. Biochem J 441:87–93
   PubMed Web of Science ®Google Scholar
• Dussault EB, Balakrishnan VK, Borgmann U, et al. (2009). Bioaccumulation of the synthetic hormone 17alpha-ethinylestradiol in the benthic invertebrates Chironomus tentans and Hyalella azteca. Ecotoxicol Environ Saf 72:1635–41
   PubMed Web of Science ®Google Scholar
• Enokizono J, Kusuhara H, Sugiyama Y. (2007). Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 72:967–75
   PubMed Web of Science ®Google Scholar
• Flint S, Markle T, Thompson S, Wallace E. (2012). Bisphenol A exposure, effects, and policy: a wildlife perspective. J Environ Manage 104:19–34
   PubMed Web of Science ®Google Scholar
• Frobenius W. (2011). “The Rabbits are Prepared …” – the development of ethinylestradiol and ethinyltestosterone. J Reproduktionsmed Endokrinol. Special Issue 1:32–57
   Google Scholar
• Gertz J, Reddy TE, Varley KE, et al. (2012). Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res 22:2153–62
   PubMed Web of Science ®Google Scholar
• Giacomini KM, Huang SM, Tweedie DJ, et al. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–36
   PubMed Web of Science ®Google Scholar
• Hanet N, Lancon A, Delmas D, et al. (2008). Effects of endocrine disruptors on genes associated with 17beta-estradiol metabolism and excretion. Steroids 73:1242–51
   PubMed Web of Science ®Google Scholar
• Hartz AMS, Madole EK, Miller DS, Bauer B. (2010a). Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. J Pharmacol Exp Ther 334:467–76
   PubMed Web of Science ®Google Scholar
• Hartz AMS, Mahringer A, Miller DS, Bauer B. (2010b). 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. J Cereb Blood Flow Metab 30:1742–55
   PubMed Web of Science ®Google Scholar
• Henriksen U, Fog JU, Litman T, Gether U. (2005). Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2. J Biol Chem 280:36926–34
   PubMed Web of Science ®Google Scholar
• Hiddemann W, Kreutzmann H, Straif K, et al. (1987). High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia. Blood 69:744–9
   PubMed Web of Science ®Google Scholar
• Hiroi T, Okada K, Imaoka S, et al. (2006). Bisphenol A binds to protein disulfide isomerase and inhibits its enzymatic and hormone-binding activities. Endocrinology 147:2773–80
   PubMed Web of Science ®Google Scholar
• Honorat M, Mesnier A, Di Pietro A, et al. (2008). Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells. Biochem Biophys Res Commun 375:308–14
   PubMed Web of Science ®Google Scholar
• Imai Y, Asada S, Tsukahara S, et al. (2003). Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol 64:610–18
   PubMed Web of Science ®Google Scholar
• Imai Y, Ishikawa E, Asada S, Sugimoto Y. (2005). Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596–604
   PubMed Web of Science ®Google Scholar
• Imai Y, Tsukahara S, Ishikawa E, et al. (2002). Estrone and 17beta-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. Jpn J Cancer Res 93:231–5
   PubMedGoogle Scholar
• Janvilisri T, Venter H, Shahi S, et al. (2003). Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem 278:20645–51
   PubMed Web of Science ®Google Scholar
• Koshiba S, An R, Saito H, et al. (2008). Human ABC transporters ABCG2 (BCRP) and ABCG4. Xenobiotica 38:863–88
   PubMed Web of Science ®Google Scholar
• Lai KM, Scrimshaw MD, Lester JN. (2002). Prediction of the bioaccumulation factors and body burden of natural and synthetic estrogens in aquatic organisms in the river systems. Sci Total Environ 289:159–68
   PubMed Web of Science ®Google Scholar
• Löscher W, Potschka H. (2005a). Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6:591–602
   PubMed Web of Science ®Google Scholar
• Löscher W, Potschka H. (2005b). Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76:22–76
   PubMed Web of Science ®Google Scholar
• Mahringer A, Fricker G. (2010). BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol. Mol Pharm 7:1835–47
   PubMedGoogle Scholar
• Mao Q. (2008). BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res 25:1244–55
   PubMed Web of Science ®Google Scholar
• Mazur CS, Marchitti SA, Dimova M, et al. (2012). Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment. Toxicol Sci 128:317–25
   PubMed Web of Science ®Google Scholar
• Milane A, Vautier S, Chacun H, et al. (2009). Interactions between riluzole and ABCG2/BCRP transporter. Neurosci Lett 452:12–16
   PubMed Web of Science ®Google Scholar
• Miller DS, Nobmann SN, Gutmann H, et al. (2000). Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 58:1357–67
   PubMed Web of Science ®Google Scholar
• Montes-Grajales D, Olivero-Verbel J. (2013). Computer-aided identification of novel protein targets of bisphenol A. Toxicol Lett 222:312–20
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Ross DD. (2012). Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer 31:73–99
   PubMed Web of Science ®Google Scholar
• Nawaz Z, Lonard DM, Dennis AP, et al. (1999). Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858–62
   PubMed Web of Science ®Google Scholar
• Nunez AA, Kannan K, Giesy JP, et al. (2001). Effects of bisphenol A on energy balance and accumulation in brown adipose tissue in rats. Chemosphere 42:917–22
   PubMed Web of Science ®Google Scholar
• Poimenova A, Markaki E, Rahiotis C, Kitraki E. (2010). Corticosterone-regulated actions in the rat brain are affected by perinatal exposure to low dose of bisphenol A. Neuroscience 167:741–9
   PubMed Web of Science ®Google Scholar
• Prasanth GK, Divya LM, Sadasivan C. (2010). Bisphenol-A can bind to human glucocorticoid receptor as an agonist: an in silico study. J Appl Toxicol 30:769–74
   PubMed Web of Science ®Google Scholar
• Renz L, Volz C, Michanowicz D, et al. (2013). A study of parabens and bisphenol A in surface water and fish brain tissue from the Greater Pittsburgh Area. Ecotoxicology 22:632–41
   PubMed Web of Science ®Google Scholar
• Robey RW, Honjo Y, van de Laar A, et al. (2001). A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta 1512:171–82
   PubMed Web of Science ®Google Scholar
• Saheki A, Terasaki T, Tamai I, Tsuji A. (1994). In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharmaceut Res 11:305–11
   PubMed Web of Science ®Google Scholar
• Silva CP, Otero M, Esteves V. (2012). Processes for the elimination of estrogenic steroid hormones from water: a review. Environ Pollut 165:38–58
   PubMed Web of Science ®Google Scholar
• Singleton DW, Khan SA. (2003). Xenoestrogen exposure and mechanisms of endocrine disruption. Front Biosci 8:s110–18
   PubMed Web of Science ®Google Scholar
• Takeshita A, Koibuchi N, Oka J, et al. (2001). Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription. Eur J Endocrinol 145:513–17
   PubMed Web of Science ®Google Scholar
• Tschugguel W, Dietrich W, Zhegu Z, et al. (2003). Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells. J Clin Endocrinol Metab 88:2281–7
   PubMed Web of Science ®Google Scholar
• Vandenberg LN, Hauser R, Marcus M, et al. (2007). Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139–77
   PubMed Web of Science ®Google Scholar
• Velamakanni S, Janvilisri T, Shahi S, van Veen HW. (2008). A functional steroid-binding element in an ATP-binding cassette multidrug transporter. Mol Pharmacol 73:12–17
   PubMed Web of Science ®Google Scholar
• Vlaming MLH, Lagas JS, Schinkel AH. (2009). Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61:14–25
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou L, Gupta A, et al. (2006). Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290:E798–807
   PubMed Web of Science ®Google Scholar
• Witorsch RJ. (2002). Endocrine disruptors: can biological effects and environmental risks be predicted? Regul Toxicol Pharmacol 36:118–30
   PubMed Web of Science ®Google Scholar
• Zhang T, Sun H, Kannan K. (2013). Blood and urinary bisphenol A concentrations in children, adults, and pregnant women from china: partitioning between blood and urine and maternal and fetal cord blood. Environ Sci Technol 47:4686–94
   PubMed Web of Science ®Google Scholar